What are the endovascular options and outcomes for repair of ascending aortic or aortic arch pathology?
- 30 November 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 32 (1), 106-110
- https://doi.org/10.1093/icvts/ivaa215
Abstract
Summary A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was ‘in patients with ascending aortic or aortic arch disease what are the outcomes with endovascular repair in terms of survival, complications and reintervention?’ Altogether 585 papers were found using the reported search, of which 9 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We found that the endovascular operative techniques with the greatest evidence were ascending aortic chimney grafts (AACs), branched thoracic endovascular aortic repair (bTEVAR) aortic grafts and fenestrated TEVAR (fTEVAR) aortic grafts. The best evidence available were small case-series or retrospective cohort studies (n < 100), with 1 systematic review, at a short follow-up period (range 0–5 years). Intraoperatively, these techniques have a high technical success rate (84–100%). We found rates of endoleak comparable between AAC (7.4–16%) and bTEVAR/fenestrated TEVAR (11.1–21.4%). Stroke rates are higher in bTEVAR (3.1–42% vs 1–26% in AACs), attributed to more proximal pathology and technically challenging procedures. Following the immediate postoperative period, the 30-day mortality is 0–10.8% and patency is 97–100%. Stroke and reintervention rates remain higher in the bTEVAR group (3.1–42.0% and 0.5–33.3%) compared to the AAC group (1.0–11.1% and 6.7–16.7%). The 3- and 5-year survival ranges from 59% to 90%, but is driven by non-aortic pathology in a high-risk population; 3-year freedom from aortic death is 93–97%. Patency is 97–100% at up to 3 years, conformation and supra-aortic occlusions thereafter remain unknown. We conclude that AACs, bTEVARs and fenestrated TEVARs are safe endovascular options in high-risk elective patients, with results comparable to open or hybrid repair. They remain unverified in acute settings or in patients fit for open intervention.Keywords
This publication has 11 references indexed in Scilit:
- Outcomes Of Chimney Technique For Aortic Arch Diseases: A Single-Center Experience With 226 CasesClinical Interventions in Aging, 2019
- iTalian RegIstry of doUble inner branch stent graft for arch PatHology (the TRIUmPH Registry)Journal of Vascular Surgery, 2019
- Orthotopic branched endovascular aortic arch repair in patients who cannot undergo classical surgeryEuropean Journal of Cardio-Thoracic Surgery, 2018
- Thoracic endovascular aortic repair with branched Inoue Stent Graft for arch aortic aneurysmsJournal of Vascular Surgery, 2017
- Outcomes of thoracic endovascular aortic repair using aortic arch chimney stents in high-risk patientsJournal of Vascular Surgery, 2017
- Branched versus fenestrated endografts for endovascular repair of aortic arch lesionsJournal of Vascular Surgery, 2016
- Editor's Choice – Subsequent Results for Arch Aneurysm Repair with Inner Branched Endografts,European Journal of Vascular and Endovascular Surgery, 2016
- Chimney Grafts in Aortic Stent Grafting: Hazardous or Useful Technique? Systematic Review of Current DataEuropean Journal of Vascular and Endovascular Surgery, 2015
- Global experience with an inner branched arch endograftThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Towards evidence-based medicine in cardiothoracic surgery: best BETSInteractive CardioVascular and Thoracic Surgery, 2003